Αποτελέσματα αναζήτησης - Renaud Capdeville

  • Εμφανίζονται 1 - 16 Αποτελέσματα από 16
Περιορισμός αποτελεσμάτων
  1. 1
    Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis

    Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis από Richard M. Stone, Paul W. Manley, Richard A. Larson, Renaud Capdeville

    Έκδοση 2018
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Revisão
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  2. 2
    Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G‐CSF mutant (Ro 25‐8315) in healthy volunteers: Comparison with single and multiple daily doses of filgrastim

    Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G‐CSF mutant (Ro 25‐8315) in healthy volunteers: Comparison with single and multiple daily dos... από Phillippe van der Auwera, E Platzer, Zhe Xu, Rainer Schulz, Olivier Feugeas, Renaud Capdeville, David J. Edwards

    Έκδοση 2001
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  3. 3
    Population pharmacokinetics of imatinib mesylate in patients with chronic‐phase chronic myeloid leukaemia: results of a phase III study

    Population pharmacokinetics of imatinib mesylate in patients with chronic‐phase chronic myeloid leukaemia: results of a phase III study από Heinz Schmidli, Bin Peng, G‐J. Riviere, Renaud Capdeville, Martee L. Hensley, Insa Gathmann, Ann E. Bolton, Amy Racine-Poon

    Έκδοση 2005
    Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  4. 4
    Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome

    Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome από Brian J. Druker, Charles L. Sawyers, Hagop M. Kantarjian, Debra Resta, Sofia Fernandes Reese, J. Ford, Renaud Capdeville, Moshe Talpaz

    Έκδοση 2001
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  5. 5
    The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML

    The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML από Michael O’Dwyer, Michael J. Mauro, Gwen Kurilik, Motomi Mori, Suzanne Balleisen, Susan B. Olson, Ellen Magenis, Renaud Capdeville, Brian J. Druker

    Έκδοση 2002
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  6. 6
    Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia

    Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia από S G O'Brien, P Meinhardt, Epperson E. Bond, Joachim Beck, B Peng, Catherine Dutreix, Günther H. Mehring, Slavica Milosavljev, Christoph Huber, Renaud Capdeville, Thomas Fischer

    Έκδοση 2003
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  7. 7
    Pharmacokinetics and Pharmacodynamics of Imatinib in a Phase I Trial With Chronic Myeloid Leukemia Patients

    Pharmacokinetics and Pharmacodynamics of Imatinib in a Phase I Trial With Chronic Myeloid Leukemia Patients από Bin Peng, Michael Hayes, Debra Resta, Amy Racine-Poon, Brian J. Druker, Moshe Talpaz, Charles L. Sawyers, Marianne Rosamilia, J. Ford, Peter Lloyd, Renaud Capdeville

    Έκδοση 2004
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  8. 8
    Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

    Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia από Brian J. Druker, Moshe Talpaz, Debra Resta, Bin Peng, Elisabeth Buchdunger, J. Ford, Nicholas Lydon, Hagop M. Kantarjian, Renaud Capdeville, Sayuri Ohno-Jones, Charles L. Sawyers

    Έκδοση 2001
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  9. 9
    Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor

    Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor από Heikki Joensuu, Peter Roberts‎, Maarit Sarlomo‐Rikala, Leif C. Andersson, Pekka Tervahartiala, David A. Tuveson, Sandra Silberman, Renaud Capdeville, Saša Dimitrijević, Brian J. Druker, George D. Demetri

    Έκδοση 2001
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  10. 10
    Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

    Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia από Hagop Kantarjian, Charles L. Sawyers, Andreas Hochhaus, François Guilhot, Charles A. Schiffer, Carlo Gambacorti‐Passerini, Dietger Niederwieser, Debra Resta, Renaud Capdeville, Ulrike Zoellner, Moshe Talpaz, Brian J. Druker

    Έκδοση 2002
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  11. 11
    A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias

    A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias από Oliver G. Ottmann, Brian J. Druker, Charles L. Sawyers, John M. Goldman, J Reiffers, Richard T. Silver, S Tura, Thomas Fischer, Michael W. Deininger, Charles A. Schiffer, Michele Baccarani, Aloïs Gratwohl, Andreas Hochhaus, Dieter Hoelzer, Sofia Fernandes‐Reese, Insa Gathmann, Renaud Capdeville, Stephen G. O’Brien

    Έκδοση 2002
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  12. 12
    Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

    Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors από George D. Demetri, Margaret von Mehren, Charles D. Blanke, Annick D. Van den Abbeele, Burton Eisenberg, Peter Roberts‎, Michael C. Heinrich, David A. Tuveson, Samuel Singer, Milos J. Janicek, Jonathan A. Fletcher, Stuart G. Silverman, Sandra Silberman, Renaud Capdeville, Beate Kiese, Bin Peng, Saša Dimitrijević, Brian J. Druker, Christopher L. Corless, Christopher D.�M. Fletcher, Heikki Joensuu

    Έκδοση 2002
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  13. 13
    Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

    Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia από Stephen G. O’Brien, François Guilhot, Richard A. Larson, Insa Gathmann, Michele Baccarani, Francisco Cervantes, Jan J. Cornelissen, Thomas Fischer, Andreas Hochhaus, Timothy P. Hughes, Klaus Lechner, Johan Lanng Nielsen, Philippe Rousselot, Josy Reiffers, Giuseppe Saglio, John D. Shepherd, Bengt Simonsson, Aloïs Gratwohl, John M. Goldman, Hagop M. Kantarjian, Kerry Taylor, Gregor Verhoef, Ann E. Bolton, Renaud Capdeville, Brian J. Druker

    Έκδοση 2003
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  14. 14
    Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE

    Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE από Nathalie Gaspar, Lynley V. Marshall, Debbie Binner, Ralf Herold, Raphaël F. Rousseau, P. Blanc, Renaud Capdeville, Jacqueline Carleer, Christopher Copland, Yannick Kerloëguen, Koen Norga, Lida Pacaud, M.-A. Sevaux, Cesare Spadoni, Jaroslav Štěrba, Franca Ligas, Tillmann Taube, Martina Uttenreuther‐Fischer, Silvia Chioato, Michael A. O’Connell, Birgit Geoerger, Jean‐Yves Blay, Jean‐Charles Soria, S.B. Kaye, Beate Wulff, Laurence Brugières, Gilles Vassal, Andrew D.J. Pearson

    Έκδοση 2018
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  15. 15
    Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents

    Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents από Andrew D.J. Pearson, C. Michel Zwaan, E. Anders Kolb, Dominik Karres, Julie Guillot, Su Young Kim, Lynley V. Marshall, Sarah K. Tasian, Malcolm A. Smith, Todd M. Cooper, Peter C. Adamson, Elly Barry, Bouchra Benettaib, Florence Binlich, Anne Borgman, Erica Brivio, Renaud Capdeville, David Delgado, Douglas V. Faller, Linda Fogelstrand, Paula G. Fraenkel, Henrik Hasle, Delphine Heenen, Gertjan J.L. Kaspers, Mark W. Kieran, Jan‐Henning Klusmann, Giovanni Lesa, Franca Ligas, Silvia Mappa, Hesham Mohamed, Andrew S. Moore, Joan Morris, Kerri Nottage, Dirk Reinhardt, Nicole Scobie, Stephen J. Simko, Thomas Winkler, Koen Norga, Gregory H. Reaman, Gilles Vassal

    Έκδοση 2020
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:
  16. 16
    ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients

    ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients από Andrew D.J. Pearson, Claudia Rössig, Giovanni Lesa, Scott J. Diede, Susan Weiner, John Anderson, Juliet C. Gray, Birgit Geoerger, Véronique Minard‐Colin, Lynley V. Marshall, Malcolm A. Smith, Paul M. Sondel, Marcis Bajars, Claudia Baldazzi, Elly Barry, Sam Blackman, P. Blanc, Renaud Capdeville, Hubert Caron, Peter D. Cole, Jorge Camarero Jiménez, Pierre Démolis, Martha Donoghue, Mabrouck Elgadi, Thomas F. Gajewski, Sara Galluzzo, Robert Ilaria, Alessandro Jenkner, Dominik Karres, Mark W. Kieran, Franca Ligas, Israel Lowy, Michael L. Meyers, Corina Oprea, Vijay Peddareddigari, Jaroslav Štěrba, Paul K. Stockman, Peter Suenaert, Uri Tabori, Cornelis van Tilburg, Todd Yancey, Brenda J. Weigel, Koen Norga, Gregory H. Reaman, Gilles Vassal

    Έκδοση 2020
    Λήψη πλήρους κειμένου Λήψη πλήρους κειμένου
    Artigo
    Προσθήκη στα αγαπημένα
    Αποθηκεύτηκε σε:

Εργαλεία αναζήτησης: